Susquehanna International Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.09M Buy
1,123,343
+686,546
+157% +$5.55M ﹤0.01% 789
2025
Q1
$3.66M Buy
436,797
+274,488
+169% +$2.3M ﹤0.01% 1545
2024
Q4
$1.29M Buy
162,309
+132,383
+442% +$1.05M ﹤0.01% 2625
2024
Q3
$249K Buy
+29,926
New +$249K ﹤0.01% 4548
2024
Q2
Sell
-666,754
Closed -$4.04M 5627
2024
Q1
$4.04M Sell
666,754
-51,249
-7% -$311K ﹤0.01% 1173
2023
Q4
$4.36M Buy
718,003
+72,147
+11% +$438K ﹤0.01% 1247
2023
Q3
$2.73M Buy
645,856
+469,308
+266% +$1.98M ﹤0.01% 1548
2023
Q2
$547K Buy
176,548
+124,893
+242% +$387K ﹤0.01% 3501
2023
Q1
$71.8K Buy
51,655
+14,267
+38% +$19.8K ﹤0.01% 5356
2022
Q4
$74.4K Sell
37,388
-26,899
-42% -$53.5K ﹤0.01% 5063
2022
Q3
$130K Sell
64,287
-729
-1% -$1.47K ﹤0.01% 5118
2022
Q2
$207K Sell
65,016
-197,127
-75% -$628K ﹤0.01% 4515
2022
Q1
$1.09M Buy
262,143
+247,856
+1,735% +$1.03M ﹤0.01% 2695
2021
Q4
$68K Sell
14,287
-604
-4% -$2.88K ﹤0.01% 5408
2021
Q3
$80K Sell
14,891
-15,955
-52% -$85.7K ﹤0.01% 5021
2021
Q2
$158K Buy
+30,846
New +$158K ﹤0.01% 4943
2021
Q1
Sell
-51,764
Closed -$237K 5149
2020
Q4
$237K Buy
51,764
+39,784
+332% +$182K ﹤0.01% 4131
2020
Q3
$46K Sell
11,980
-13,674
-53% -$52.5K ﹤0.01% 4229
2020
Q2
$122K Sell
25,654
-194,074
-88% -$923K ﹤0.01% 3874
2020
Q1
$765K Sell
219,728
-89,254
-29% -$311K ﹤0.01% 2345
2019
Q4
$1.49M Sell
308,982
-46,699
-13% -$225K ﹤0.01% 1581
2019
Q3
$1.03M Buy
355,681
+276,897
+351% +$803K ﹤0.01% 1987
2019
Q2
$565K Buy
+78,784
New +$565K ﹤0.01% 2790
2019
Q1
Sell
-12,621
Closed -$171K 3004
2018
Q4
$171K Buy
12,621
+3,105
+33% +$42.1K ﹤0.01% 3008
2018
Q3
$211K Sell
9,516
-155,260
-94% -$3.44M ﹤0.01% 2713
2018
Q2
$2.7M Buy
+164,776
New +$2.7M ﹤0.01% 849